Cargando…
Effect of Concurrent Use of Memantine on the Efficacy of Masupirdine (SUVN-502): A Post Hoc Analysis of a Phase 2 Randomized Placebo-Controlled Study
INTRODUCTION: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive deterioration in cognition, memory and activities of daily living. Selective blockade of serotonin-6 (5-HT(6)) receptors, which are exclusively localized to the central nervous system, is reported to...
Autores principales: | Nirogi, Ramakrishna, Goyal, Vinod Kumar, Benade, Vijay, Subramanian, Ramkumar, Ravula, Jyothsna, Jetta, Satish, Shinde, Anil, Pandey, Santosh Kumar, Jayarajan, Pradeep, Jasti, Venkat, Cummings, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588135/ https://www.ncbi.nlm.nih.gov/pubmed/35908254 http://dx.doi.org/10.1007/s40120-022-00390-4 |
Ejemplares similares
-
Potential beneficial effects of masupirdine (SUVN‐502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses
por: Nirogi, Ramakrishna, et al.
Publicado: (2022) -
Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study
por: Nirogi, Ramakrishna, et al.
Publicado: (2022) -
Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders
por: Nirogi, Ramakrishna, et al.
Publicado: (2023) -
Efficacy of Memantine Hydrochloride in Neuropathic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019) -
Pharmacodynamics of Memantine: An Update
por: Rammes, G, et al.
Publicado: (2008)